Before our resident expert weighs in on this question, let me take a crack at it.
I would agree with Medchem. End of story..lol.
Ok seriously, other then the news about Phizer's vaccine, which has been said all along has it's own issues with efficacy to the masses, as well as a potentially mutating virus which could render it obsolete. But maybe most relevant, the trust factor with 50% of the US population surveyed as "don't trust it, or any vaccines".
Let's also remember what CJM stated, there will "always be a need for therapeutics". They are not in competition with eachother.
Let's also not forget! Ifenprodil has shown potential to reverse the lung damage already suffered by those infected and since recovered.
As for therapeutics? I'm not aware of any, at least in our class, that are potentially "stealing our thunder". There is the antibody treatment, which is cost prohibitive to most, and a logistics challenge to distribute.
To think, after all of this time, Algernon would "Jump the Shark" so close to a full trial data readout, is illogical to me.
Just my take on things, nothing expert about it in the least.
But Smoki is right!
Roll 1 up and chill... the only clinically tested and data proven Modus Operandi here at Algernon.
LS5
News 
Market Data 
Discover 
